Skip to content

13F-HR filed by Ghost Tree Capital, LLC

Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-15, with 64 holding rows worth $278,093,000.

Accession
0001140361-15-020001
Filed
2015-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2015

A holdings report, 64 entries on the cover page, a total value of $278,093,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $278,093,000 with VALUE read as thousands by filing date, 13F file number 028-16059. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPDR SER TR78464A870S&P BIOTECH100,000$22,550,000thousands by filing dateput
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock100,000$11,752,000thousands by filing date
ACTAVIS PLCG0083B108SHS35,000$10,417,000thousands by filing date
ENDO HEALTH SOLUTIONS INC29264FAB2BOND90,000$8,073,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK150,000$7,842,000thousands by filing date
NUVASIVE INC670704105COM160,000$7,358,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK30,000$7,083,000thousands by filing date
ZS PHARMA INC98979G105Common Stock165,000$6,943,000thousands by filing date
ZELTIQ AESTHETICS INC98933Q108COM225,000$6,937,000thousands by filing date
CELGENE CORP151020104COM60,000$6,917,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock180,000$6,833,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM120,000$6,028,000thousands by filing date
DYAX CORP26746E103COM350,000$5,864,000thousands by filing date
MERIT MED SYS INC COM589889104Stock300,000$5,775,000thousands by filing date
Merck & Co.,Inc.58933Y105COM100,000$5,748,000thousands by filing date
WRIGHT MED GROUP INC98235T107COM200,000$5,160,000thousands by filing date
BECTON DICKINSON & CO075887109COM35,000$5,026,000thousands by filing date
GENOCEA BIOSCIENCES INC372427104COM420,000$4,981,000thousands by filing date
NUVASIVE INC670704105COM100,000$4,599,000thousands by filing datecall
Alcobra LtdM2239P109SHS800,000$4,504,000thousands by filing date
AVALANCHE BIOT05337G107Common Stock110,000$4,457,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM35,000$4,362,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW1,750,000$4,288,000thousands by filing date
CEPHEID15670R107COM75,000$4,268,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock40,000$4,177,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock100,000$4,155,000thousands by filing datecall
REVANCE THERAPEUTICS INC761330109COM200,000$4,146,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS45,000$4,101,000thousands by filing date
AbbVie,Inc.00287Y109COM70,000$4,098,000thousands by filing date
AVALANCHE BIOT05337G107Common Stock100,000$4,052,000thousands by filing datecall
ACADIA HEALTHCARE COMPANY INC COM00404A109Stock120,000$3,911,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock175,000$3,854,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM350,000$3,808,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM375,000$3,698,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM60,000$3,651,000thousands by filing date
THERAPEUTICSMD INC88338N107COM600,000$3,630,000thousands by filing date
BLUEBIRD BIO INC09609G100COM30,000$3,623,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON200,000$3,596,000thousands by filing date
INOGEN INC45780L104COM110,000$3,519,000thousands by filing date
VITAE PHARMACEUTICALS INC92847N103COM300,000$3,513,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR150,000$3,504,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM335,000$3,414,000thousands by filing date
ENTELLUS MED INC29363K105COM150,000$3,285,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW75,000$3,087,000thousands by filing date
DISCOVERY LABORATORIES INC N254668403COM NEW2,500,000$2,975,000thousands by filing date
PERNIX THERAPEUTICS HOLDINGS71426V108COM250,000$2,673,000thousands by filing date
IGNYTA INC451731103COM250,000$2,488,000thousands by filing date
Lion Biotechnologies53619R102COM200,000$2,422,000thousands by filing date
TETRAPHASE PHARMACEUTICALS INC88165N105COMMON STOCK65,000$2,382,000thousands by filing date
APPLIED GENETIC TECHNOL CORP03820J100COM116,750$2,334,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock100,000$2,285,000thousands by filing date
LOXO ONCOLOGY INC548862101COM175,000$2,179,000thousands by filing date
EPIZYME INC29428V104COM115,000$2,160,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM200,000$2,100,000thousands by filing datecall
CELLADON CORP15117E107Cmn100,000$1,894,000thousands by filing date
UNILIFE CORP NEW90478E103COM450,000$1,805,000thousands by filing date
ADVAXIS INC007624208COM NEW125,000$1,805,000thousands by filing date
INSULET CORP COM45784P101Stock50,000$1,668,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM125,000$1,655,000thousands by filing date
KINDRED BIOSCIENCES INC COM494577109Stock100,500$718,000thousands by filing date
BIOLASE INC090911108COMMON STOCK300,000$606,000thousands by filing date
OCERA THERAPEUTICS INC COM67552A108COM125,000$589,000thousands by filing date
GLOBEIMMUNE INC37957B100COM68,973$506,000thousands by filing date
XOMA CORP DEL98419J107COM72,000$262,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-15-020001this filing2015-05-15acceptance time not in the bulk data set
13F-HR/A 0001140361-15-020402 base2015-05-15acceptance time not in the bulk data set